Last Updated on July 28, 2021 by HepFree NYC
Related Articles
-
FDA Approves Zepatier for Treatment of Hep C
The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
-
-
Funding | Innovative Hepatitis C Care and Treatment Models for People Who Inject Drugs (NYS DOH)
This RFA will support 3 innovative HCV care and treatment models that will address the needs and the barriers PWID with HCV face when accessing HCV services in traditional health care settings.
-
Coney Island Russian Hep C Support Group
Bringing awareness of Hepatic disease to Russian community.
-
Report Medicaid Managed Care Pharmacy & Medication ‘Issues’ to NYS DOH Pharmacy Program
Report Medicaid Managed Care Pharmacy & Medication ‘Issues’ to NYS DOH Pharmacy Program by describing the issue in detail in an email to: PPNO@Health.state.ny.US. Medical Providers, Patient Navigators, Case Managers, Care Managers, Advocates, Pharmacists, Patients...
-
Letter to Administration: “America Falls Behind in Hepatitis Elimination Efforts”
More than 60 organizations, including NVHR, signed onto a letter urging the Trump administration to invest in the Department of Health & Human Services Viral Hepatitis Action Plan
-
Hep C Patients needed for Market Research ($50)
This is a great opportunity to voice your opinions! Participation in this research contributes towards advancing the quality of treatment and care for those diagnosed with Hepatitis C. Qualified participants will earn $50 for joining our panel, plus the opportunity to earn more m...
-
NYC DOHMH’s Request to Upgrade USPSTF’s Baby Boomer HCV Testing Rating
The USPSTF's draft recommendations on testing hepatitis C among injection drug users and others at high risk is a major improvement over previous guidelines (a grade “B”, meaning testing is recommended). However, the Task Force failed to match the Centers for Disease Control ...
